Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
OA02 - A New Vision of Targets and Strategies
- 10:30 - 12:00
- 9/08/2019
- Location: Seoul (2007)
- IASLC CME Accredited
- Type: Oral Session
- Track: Targeted Therapy
- Moderators:Frank Griesinger, Luis Paz-Ares
-
+
OA02.05 - First-In-Human Phase 1/2 Trial of Anti-AXL Antibody–Drug Conjugate (ADC) Enapotamab Vedotin (EnaV) in Advanced NSCLC
11:15 - 11:25 | Presenter: Suresh S Ramalingam | Author(s): Juanita Lopez, Morten Mau-Sorensen, Fiona Thistlethwaite, Sarina Piha-Paul, Shirish Gadgeel, Yvette Drew, Pasi A Jänne, Aaron S. Mansfield, Guang Chen, Ulf Forssmann, Hrefna Kristin Johannsdottir, Nora Pencheva, Annette Ervin-Haynes, Ignace Vergote
- Abstract
Loading...
-
+
OA04 - Immuno Combinations and the Role of TMB
- 15:15 - 16:45
- 9/08/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Solange Peters, Martin Reck
-
+
OA04.05 - KEYNOTE-021: TMB and Outcomes for Carboplatin and Pemetrexed With or Without Pembrolizumab for Nonsquamous NSCLC
16:00 - 16:10 | Presenter: Corey Jay Langer | Author(s): Shirish Gadgeel, Hossein Borghaei, Amita Patnaik, Steven F. Powell, Ryan D Gentzler, James Chih-Hsin Yang, Matthew A. Gubens, Lecia Sequist, Mark Awad, Razvan Cristescu, Deepti Aurora-Garg, Andrew Albright, Andrey Loboda, Julie Kobie, Jared K. Lunceford, Mark Ayers, Gregory M Lubiniecki, Bilal Piperdi, M. Catherine Pietanza, Vassiliki A Papadimitrakopoulou
- Abstract
Loading... -
+
OA04.06 - Evaluation of TMB in KEYNOTE-189: Pembrolizumab Plus Chemotherapy vs Placebo Plus Chemotherapy for Nonsquamous NSCLC
16:10 - 16:20 | Presenter: Marina Chiara Garassino | Author(s): Delvys Rodriguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Giovanna Speranza, Martin Reck, Rina Hui, Michael Boyer, Razvan Cristescu, Deepti Aurora-Garg, Andrew Albright, Andrey Loboda, Julie Kobie, Jared K. Lunceford, Mark Ayers, Gregory M Lubiniecki, Bilal Piperdi, M. Catherine Pietanza, Edward Garon
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-127 - Antitumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 in NSCLC with EGFR Exon 20 Insertions
09:45 - 09:45 | Presenter: Gregory J Riely | Author(s): Joel W Neal, D. Ross Camidge, Alexander Spira, Zosia Piotrowska, Leora Horn, Daniel B Costa, Anne Tsao, Jyoti D Patel, Shirish Gadgeel, Lyudmila Bazhenova, Viola W. Zhu, HOWARD WEST, Sylvie Vincent, Jian Zhu, Shu Jin, Steven Zhang, Shuanglian Li, Pasi A Jänne
- Abstract
Loading... -
+
P1.01-71 - Bone Metastases and Skeletal-Related Events in Patients with Metastatic NSCLC Treated with ICIs: A Multi-Institutional Study
09:45 - 09:45 | Presenter: Angel Qin | Author(s): Songzhu Zhao, Abdul Miah, Lai Wei, Sandip Patel, Andrew Johns, Madison Grogan, Erin M. Bertino, Kai He, Sope O Olugbile, Peter Shields, Gregory Kalemkerian, Shirish Gadgeel, Nithya Ramnath, Bryan J. Schneider, Khaled Hassan, David P Carbone, Carolyn J Presley, Gregory A Otterson, Dwight Hall Owen
- Abstract
Loading...
-
+
IS12 - Symposium by Medscape: Expanding the Therapeutic Landscape Of Advanced NSCLC Targeting HER2 (Not IASLC CME Accredited)
- 07:00 - 08:00
- 9/09/2019
- Location: Hilton Head (1978)
- Type: Industry Symposia & Workshops
- Track:
-
+
MS05 - Novel Biological Pathways and Druggable Targets
- 11:00 - 12:30
- 9/09/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Biology
- Moderators:Jin Jen, Marisol Arroyo-Hernandez
-
+
MS05.03 - Notch Signalling
11:30 - 11:45 | Presenter: Shirish Gadgeel
- Abstract
Loading...
-
+
MA25 - Precision Medicine in Advanced NSCLC
- 14:30 - 16:00
- 9/10/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Sebastian Defranchi, Karen Kelly
-
+
MA25.01 - Pembrolizumab Plus Chemotherapy for Advanced NSCLC Without Tumor PD-L1 Expression: Pooled Analysis of KN021G, KN189 and KN407
14:30 - 14:37 | Presenter: Hossein Borghaei | Author(s): Corey Jay Langer, Luis Paz-Ares, Delvys Rodriguez Abreu, Balazs Halmos, Vassiliki A Papadimitrakopoulou, Marina Chiara Garassino, Baerin Houghton, Takayasu Kurata, Ying Cheng, Jianxin Lin, M. Catherine Pietanza, Bilal Piperdi, Shirish Gadgeel
- Abstract
Loading...